the Effect of Hyaluronic Acid Intrauterine Wash on Endometrial Receptivity and Pregnancy Outcome
NCT ID: NCT06937645
Last Updated: 2025-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2
120 participants
INTERVENTIONAL
2023-09-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intrauterine Injection of Human Chorionic Gonadotrophin and Pregnancy Rate in ICSI
NCT03445910
Intrauterine Injection of HCG and Implantation Rate
NCT01933126
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
NCT01768247
Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI
NCT04606082
Endometrial Curettage Before Embryo Transfer
NCT00367367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the uterine cavity washed with hyaluronic acid preparation on the day of ooc
40 infertile patients had their uterine cavity with hyaluronic acid preparation on the day of oocytes retrieval in ICSI
Hyaluronic Acid (HA)
hyaluronic acid PRP preparation used to wash the endometrium on the day of oocytes retrieval
40 infertile females had their uterine cavity washed with PRP preparation
40 infertile females had their uterine cavity washed with PRP preparation on the day of oocytes retrieval in ICSI
platlet rich plasma (PRP)
PRP preparation used to wash the uterine cavity on the day of oocytes retrieval
40 infertile females with no intervention for their uterus
40 infertile females with no intervention for their uterus on the day of oocytes retrieval in ICSI
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyaluronic Acid (HA)
hyaluronic acid PRP preparation used to wash the endometrium on the day of oocytes retrieval
platlet rich plasma (PRP)
PRP preparation used to wash the uterine cavity on the day of oocytes retrieval
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infertile females scheduled for GnRH antagonist protocol of fresh ICSI cycle.
* Females use dual stimulation (GnRH agonist plus Ovetrelle) for ovulation triggering.
Exclusion Criteria
* Infertile females diagnosed with uterine pathology.
* Infertile females who are scheduled for a frozen ICSI cycle.
* Infertile females diagnosed with endocrine diseases like thyroid disease, diabetes mellitus, and hyperprolactinemia.
* Infertile females diagnosed with thrombocytopenia.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Nahrain University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ghada bassim raaf
clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
high institute for infertility diagnosis and ARTS
AL-Kadimya, Baghdad Governorate, Iraq
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0701-PF-2023G12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.